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Analysis of cellular 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxo-dGuo) as a biomarker of oxidative
DNA damage has been fraught with numerous methodological problems. This is primarily due to artifactual
oxidation of dGuo that occurs during DNA isolation and hydrolysis. Therefore, it has become necessary
to rely on using the comet assay, which is not necessarily speciﬁc for 8-oxo-dGuo. A highly speciﬁc and
sensitive method based on immunoafﬁnity puriﬁcation and stable isotope dilution liquid chromatography
(LC)-multiple reaction monitoring (MRM)/mass spectrometry (MS) that avoids artifact formation has
now been developed. Cellular DNA was isolated using cold DNAzol (a proprietary product that contains
guanidine thiocyanate) instead of chaotropic- or phenol-based methodology. Chelex-treated buffers were
used to prevent Fenton chemistry-mediated generation of reactive oxygen species (ROS) and artifactual
oxidation of DNA bases. Deferoxamine was also added to all buffers in order to complex any residual
transition metal ions remaining after Chelex treatment. The LC-MRM/MS method was used to determine
that the basal 8-oxo-dGuo level in DNA from human bronchoalveolar H358 cells was 2.2 ( 0.4 8-oxo-
dGuo/107 dGuo (mean ( standard deviation) or 5.5 ( 1.0 8-oxo-dGuo/108 nucleotides. Similar levels
were observed in human lung adenocarcinoma A549 cells, mouse hepatoma Hepa-1c1c7 cells, and human
HeLa cervical epithelial adenocarcinoma cells. These values are an order of magnitude lower than is
typically reported for basal 8-oxo-dGuo levels in DNA as determined by other MS- or chromatography-
based assays. H358 cells were treated with increasing concentrations of potassium bromate (KBrO3)a s
a positive control or with the methylating agent methyl methanesulfonate (MMS) as a negative control.
A linear dose-response for 8-oxo-dGuo formation (r2 ) 0.962) was obtained with increasing concentrations
of KBrO3 in the range of 0.05 mM to 2.50 mM. In contrast, no 8-oxo-dGuo was observed in H358 cell
DNA after treatment with MMS. At low levels of oxidative DNA damage, there was an excellent
correlation between a comet assay that measured DNA single strand breaks (SSBs) after treatment with
human 8-oxo-guanine glycosylase-1 (hOGG1) when compared with 8-oxo-dGuo in the DNA as measured
by the stable isotope dilution LC-MRM/MS method. Availability of the new LC-MRM/MS assay made
it possible to show that the benzo[a]pyrene (B[a]P)-derived quinone, B[a]P-7,8-dione, could induce 8-oxo-
dGuo formation in H358 cells. This most likely occurred through redox cycling between B[a]P-7,8-
dione and B[a]P-7,8-catechol with concomitant generation of DNA damaging ROS. In keeping with this
concept, inhibition of catechol-O-methyl transferase (COMT)-mediated detoxiﬁcation of B[a]P-7,8-catechol
with Ro 410961 caused increased 8-oxo-dGuo formation in the H358 cell DNA.
Introduction
Elevated levels of oxidatively damaged DNA have been
measured in numerous diseases including Alzheimer’s disease
(1), Parkinson’s disease (2), autoimmune diseases (3), cardio-
vascular diseases (4-6), and cancer (7-9). It has been suggested
that such damage plays an important role in the etiology of these
diseases (10, 11). Oxidative DNA damage is also increased
through exposure to environmental chemicals (12, 13). In
addition, there is some evidence of a link between ingestion of
antioxidants and reduced oxidative damage to DNA (14). 8-oxo-
dGuo1 is by far the most extensively studied lesion that arises
as a consequence of oxidative DNA damage (5, 11, 15).
Unfortunately, it is extremely easy to induce artifactual
formation of 8-oxo-dGuo in cellular DNA during the isolation
and hydrolysis procedures that are commonly used (5, 16).
Therefore, a number of studies have been conducted to address
the problem of quantifying 8-oxo-dGuo in DNA including the
important contributions of the Cadet group (17, 18) and the
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(19-25). The comet assay has predicted that basal endogenous
concentrations of 8-oxo-dGuo in cellular DNA should be at the
level of 3-5 molecules of 8-oxo-dGuo/107 dGuo (25). Unfor-
tunately, physicochemical methods developed to analyze 8-oxo-
dGuo have consistently obtained values that are almost an order
of magnitude higher at 34-37 molecules of 8-oxo-dGuo/107
dGuo (25). These elevated values were obtained even when
highly speciﬁc and sensitive methodology based on immunoaf-
ﬁnity puriﬁcation and stable isotope dilution LC-MS was used
(26), which suggests that artifactual formation of 8-oxo-dGuo
might occur during DNA isolation and hydrolysis (5, 16).
Signiﬁcant advances have been made to the comet assay by
introducing the use of hOGG1 to speciﬁcally remove 8-oxo-
dGuo from the DNA so that it is now possible to reliably
measure basal cellular oxidative DNA damage (27). hOGG1 is
known to excise both 8-oxo-dGuo as 8-oxo-Gua (7,8-dihydro-
8-oxo-guanine) producing a single strand break. It will also
remove formamidopyrimidine-dGuo (FAPY-dGuo) derived to
yield a single strand break. Unfortunately, a linear dose-response
to KBrO3-induced oxidative DNA damage was not obtained
even with this signiﬁcantly improved method (27). This implies
that lesions other than 8-oxo-dGuo can be detected by the comet
assay even when the assay is used in combination with the
selective hOGG1 enzyme.
We have developed an immunoafﬁnity puriﬁcation stable
isotope dilution LC-MRM/MS assay for the analysis of 8-oxo-
dGuo in cellular DNA. This methodology provides the ultimate
in sensitivity and speciﬁcity that can be attained using physi-
cochemical methodology for the analysis of endogenously
generated lesions in DNA (28). Unfortunately, when this assay
was used with conventional DNA isolation procedures, basal
levels of 8-oxo-dGuo were similar to those described previously
(26). Artifactual generation of 8-oxo-dGuo was reduced when
cellular DNA was isolated using commercially available DNA-
zol (which contains high concentrations of guanidine thiocy-
anate) (29) instead of chaotropic- (30, 31) or phenol-based (32)
extraction methodology. Chelex-treated water was used to
reduce transition metal ion contamination in the buffers that
were used (33), and deferoxamine was added to complex any
residual transition metal ions that were present. This prevented
Fenton chemistry-mediated generation of ROS and artifactual
oxidation of DNA bases (5, 16). Levels of 8-oxo-dGuo obtained
when using these precautions were then similar to those obtained
previously using the comet assay (27). The assay was then
employed to quantify 8-oxo-dGuo in human lung bronchoal-
veolar H358 cells treated with the redox-active B[a]P-7,8-dione,
a reaction product of aldo-keto reductase (AKR)-mediated
polycyclic aromatic hydrocarbon (PAH)-trans-dihydrodiol ac-
tivation (34).
Materials and Methods
Chemicals and Materials. 8-Oxo-dGuo, dGuo, deferoxamine
methanesulfonate, TEMPO (2,2,6,6-tetramethylpiperidin-1-oxyl),
shrimp alkaline phosphatase (SAP), dimethylsulfoxide (DMSO),
MMS, KBrO3, Dulbecco’s phosphate buffered saline (PBS),
ascorbic acid, cupric chloride, and hydrogen peroxide were obtained
from Sigma-Aldrich (St. Louis, MO). [15N5]-2′-deoxyguanosine
triphosphate (dGTP) was purchased from Cambridge Isotope
Laboratories Inc. (Andover, MA). Bovine pancreas deoxyribonu-
clease 1 (DNase 1) was obtained from Calbiochem (San Diego,
CA), phosphodiesterase 1 was purchased from Worthington (Lake-
wood, NJ), and 3-(N-morpholino)propanesulfonic acid (MOPS) was
from Fluka Biochemika (Milwaukee, WI). Chelex 100 resin was
purchased from Bio-Rad (Hercules, CA). CNBr-activated Sepharose
4B was obtained from Amersham Pharmacia Biotech (Piscataway,
NJ). Kontes Flex polystyrene columns (5.0 × 1.0 cm) were obtained
from Fisher Scientiﬁc (Pittsburgh, PA). Costar Spin-X centrifuge
ﬁlter tubes (0.22 µm, nylon) and HPLC grade solvents were
purchased from Fisher Scientiﬁc (Pittsburgh, PA). The 8-oxo-dGuo
monoclonal antibody (mAb) 4E9 was purchased from Trevigen Inc.
(Gaithersburg, MD). Chelex-mediated removal of transition metal
ions was assessed by monitoring the absorbance of solutions at
260 nm for 2 h. This enabled the detection of >10 nM transition
metal ions (33).
LC. Puriﬁcation of [15N5]-8-oxo-dGuo and DNA base analysis
were performed using a Hitachi HPLC system equipped with an
L-2130 pump, an L-2200 autosampler, and an L-2450 diode array
detector (systems 1 and 2). LC-MS analysis of 8-oxo-dGuo was
performed using an Agilent 1100 series HPLC pump (Agilent
Technologies, Santa Clara, CA) (system 3). LC system 1 utilized
a YMC ODS-AQ C18 column (250 × 10 mm internal diameter
(i.d.), 5 µm), and system 2 employed a Phenomenex Luna C18 (2)
column (250 × 4.6 mm i.d.; 5 µm) with a guard column cartridge
(C18; 4 × 3.0 mm i.d.). LC system 3 used a Phenomenex Luna
C18(2) (150 × 2 mm i.d.; 3 µm) with a C18 guard column cartridge
(4 × 2 mm i.d.). For LC systems 1 and 2, solvent A was water,
and solvent B was acetonitrile. The linear gradient for system 1
was 6% B at time 0 min, 6% B at time 3 min, 12% B at 9 min,
12% B at 12 min, 6% B at 15 min, and 6% B at 25 min with a
ﬂow of 2.5 mL/min. The linear gradient for system 2 was 5% B at
0 min, 15% B at 12 min, 80% B at 14 min, 80% B at 20 min, 5%
B at 22 min, and 5% B at 30 min with a ﬂow rate of 0.8 mL/min.
For system 3, the mobile phase consisted of water with 0.02%
formic acid as solvent A and acetonitrile as solvent B. The linear
gradient for system 3 was as follows: 2% B at 0 min, 15% B at 15
min, 15% B at 16 min, 2% B at 17 min, and 2% B at 27 min with
a ﬂow rate of 0.2 mL/min.
LC-MS. Analyses were conducted using an API 4000 (Applied
Biosystems/MDS Sciex, Foster City) equipped with positive
electrospray ionization (ESI), CTC autosampler (CTC Analytics,
Switzerland), and Analyst 1.4.1 software. Samples were maintained
at 5 °C on the autosampler, and injections of 50 µL were made.
The column efﬂuent was diverted to waste for the ﬁrst 5 min and
the last 12 min of the analysis to prevent extraneous material from
entering the mass spectrometer. The API 4000 operating conditions
were as follows: compressed air as curtain gas (17 psi) and nitrogen
as nebulizing (35 psi), heater (10 psi), and collision-induced
dissociation (CID) gas (6 psi). The ESI probe temperature was 450
°C, the declustering potential was 46 V, the entrance potential was
10 V, the collision energy was 19 eV, and the collision exit potential
was 30 V. MRM was conducted by using the m/z 284 (MH+) f
m/z 168 [MH+-2′-deoxyribose+H] transition for 8-oxo-dGuo and
m/z 289 (MH+) f m/z 173 [MH+-2′-deoxyribose+H] transition
for [15N5]-8-oxo-dGuo.
Synthesis of [15N5]-8-Oxo-dGuo. A solution of 15N5-dGTP (2
mg, 3.6 µmmol) in 200 µL of water was added to a solution (2
mL) of 10 mM MOPS, 100 mM NaCl (pH 7.0) buffer, and 250
units of E. coli alkaline phosphatase. The reaction mixture was then
incubated at 37 °Cf o r1h .[ 15N5]-dGuo was puriﬁed on LC system
1. The fractions containing [15N5]-dGuo were collected, pooled, and
evaporated to dryness to furnish pure [15N5]-dGuo (776 µg, 73%
yield). A solution of [15N5]-dGuo (100 µg, 0.366 µmol) in water
(400 µL) was added to an aqueous solution made from 2 M ascorbic
acid (26 µL), 0.2 M cupric chloride (2.6 µL), and 30% hydrogen
peroxide (52 µL). The reaction mixture was vortex-mixed, placed
on ice for 15 min, and then puriﬁed using LC system 1. The identity
and isotopic purity of the [15N5]-8-oxo-dGuo was conﬁrmed by LC-
tandem MS (MS/MS) analysis.
Cell Culture. Human bronchoalveolar H358 cells, human lung
adenocarcinoma A549 cells, human cervical adenocarcinoma HeLa
cells, and Mouse hepatoma Hepa-1c1c7 cells were obtained from
the American type Culture Collection (ATCC #s CRL-5807, CCL-
185, CCL-2, and CRL-2026, respectively). H358 cells were cultured
and maintained in RPMI 1640 nutrient mixture, A549, and Hepa-
1c1c7 cells were cultured and maintained in DMEM medium with
10% fetal bovine serum, 1% L-glutamine, and 100 units/mL of
penicillin/streptomycin. HeLa cells were cultured in Eagle’s
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1% L-glutamine, and 100 units/mL of penicillin/streptomycin. All
cells were incubated at 37 °C in a humidiﬁed atmosphere containing
5% CO2 and were passaged every 3 days at a 1:5 dilution.
Determination of Basal 8-Oxo-dGuo Concentrations. H358,
A549, HeLa, or Hepa1c1c7 cells were allowed to come to
∼40-50% conﬂuence, the RPMI or DMEM media were removed.
Cells (typically 106) were washed with Dulbecco’s PBS (5 mL)
then transferred with 400 µL of Dulbecco’s PBS buffer containing
proteinase K (80 µg )t oa2m Lcentrifuge tube. They were then
diluted to 2 mL with RPMI, centrifuged at 100g, and the supernatant
removed. The cell pellet was resuspended in 100 µL of RPMI media
followed by either the DNAzol reagent (900 µL) or the Wako lysis
solution (900 µL). The DNAzol reagent uses a novel proprietary
guanidine-detergent lysing solution that hydrolyzes RNA and
allows the selective precipitation of DNA from cell lysates (29).
For the DNAzol method, the suspension was incubated for 10 min
at room temperature, and isopropanol (400 µL) was added. The
tube was shaken by hand for 3-4 min, left standing at room
temperature for 10 min, and centrifuged at 2,400g for 10 min. The
supernatant was removed, 75% aqueous ethanol (1 mL) was added,
centrifuged 2,400g, and the supernatant again removed. Another
aliquot of 75% aqueous ethanol (1 mL) was added, the tube was
shaken by hand for 3-4 min, and then cooled at - 80 °C overnight.
For the Wako method, the 2 mL centrifuge tube was shaken by
hand for 5 min and then centrifuged at 2,400g for 10 min. The
supernatant was removed, and another portion of the Wako lysis
solution (1 mL) was added. The tube was shaken again by hand
for 5 min and centrifuged at 2,400g for 10 min. After removing
the supernatant, the pellet was resuspended in 200 µL of Wako
enzyme solution followed by 10 µL of Wako protease solution,
which were mixed by inversion of the tubes by hand for 3-4 min.
The mixture was incubated for1ha t3 7°C. The sodium iodide
solution (300 µL) together with isopropanol (500 µL) were then
added and shaken by hand for 5 min, left at room temperature for
10 min, and then centrifuged at 2,400g for 10 min. The supernatant
was removed, 75% ethanol (1 mL) was added, and centrifuged for
10 min at 2,400g. After removal of the supernatant, another portion
of 75% ethanol (1 mL) was added and the tube kept at -80 °C
overnight. For both the DNAzol and Wako methods, DNA was
isolated by centrifugation of the cold 75% ethanol solutions at
2,400g for 10 min, removal of the supernatant, and allowing to
air-dry for 2 min. The DNA was then immediately hydrolyzed as
described below.
DMSO, KBrO3, and MMS Treatment of H358 cells. Cells
were allowed to come to ∼40-50% conﬂuence. The RPMI media
was removed; cells were washed with 10 mL of Hank’s balanced
salt solution (HBSS) and resuspended in HBSS (10 mL). They were
then treated with KBrO3 in increasing concentrations from 0.05
mM to 2.50 mM in Dulbecco’s PBS or MMS in increasing
concentrations from 5 µMt o2 0µM dissolved in DMSO (ﬁnal
DMSO concentration of 2%). The H358 cells were also treated
with PBS (control) or DMSO (0.01% to 2.00%). Cells (typically
106) were incubated for 3 h, the HBSS was removed, they were
washed with Dulbecco’s PBS (5 mL), and transferred toa2m L
centrifuge tube in 400 µL of Dulbecco’s PBS buffer containing
proteinase K (80 µg). Cells were then diluted to 2 mL with RPMI
media and a portion of the cell suspension was used for the comet
assay (20 µL). The remainder was centrifuged at 100g, the
supernatant removed, and the cell pellet resuspended in 100 µLo f
RPMI media followed by 900 µL of DNAzol reagent, the DNA
isolated as described above, and hydrolyzed as described below.
B[a]P-7,8-dione Treatment of the H358 Cells. Cells (typically
106) were resuspended in HBSS as described above and then treated
with 20 µMB [ a]P-7,8-dione (Scheme 1) dissolved in DMSO (ﬁnal
concentration 1%) or DMSO vehicle alone (ﬁnal concentration 1%)
for 9 h. Cells were also pretreated with COMT inhibitor Ro 410961
(3 µM) dissolved in 40% ethanol (ﬁnal ethanol concentration
0.04%). The cells were incubated for 30 min and treated either
with 20 µMB [ a]P-7,8-dione dissolved in DMSO (ﬁnal concentra-
tion 1%) or with DMSO vehicle alone (ﬁnal concentration 1%)
and the cells incubated for a further 9 h. Cells were then harvested
as described above. The DNA was isolated, hydrolyzed, puriﬁed,
and analyzed for 8-oxo-dGuo by stable isotope dilution LC-MRM/
MS as described below.
DNA Hydrolysis and Puriﬁcation. DNA pellets (obtained as
described above) were dissolved in 300 µL of Chelex-treated 10
mM MOPS containing 100 mM MgCl2 at pH 7.0 and 0.1 mM
deferoxamine. The internal standard [15N5]-8-oxo-dGuo (0.76 ng)
was added and enzymatic hydrolysis initiated by the addition of
556 units of DNase 1 followed by incubation for 90 min at 37 °C.
At the end of the incubation, 30 µL of 0.2 M Chelex-treated glycine
buffer (pH 10) was added together with phosphodiesterase I (100
units/mL in Chelex-treated water) and 10 µL of 500 mM MgCl2.
Samples were then incubated for a further2ha t3 7°C before
adding the SAP solution (6 units, 6 µL). The samples were
incubated for an additional 90 min at 37 °C. Finally, the samples
were ﬁltered through Costar 0.22 µM nylon ﬁlters. A portion of
Scheme 1. B[a]P-7,8-dione-Mediated Formation of 8-Oxo-dGuo in H358 Cells
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and the remaining sample was used for normal base analysis on
LC system 2.
Immunoafﬁnity Column Preparation. The columns were
prepared by minor modiﬁcations to the previously published method
of Singh et al. (26). CNBr-activated Sepharose 4B gel (0.7 g) was
suspended in 45 mL of 1 mM HCl in a 50 mL Falcon tube and
gently shaken for 15 min on a rocking platform. The suspended
gel was centrifuged for 5 min at 3,210g using a Beckman GS-6KR
centrifuge (Cambridge Scientiﬁc, Cambridge, MA) and the super-
natant discarded. The gel was washed four times using 45 mL of
1 mM HCl by gentle shaking for 15 min followed by centrifugation
for 5 min at 3,210g and removal of the supernatant. Contents of
the Falcon tube were transferred to a 1 × 5 cm polystyrene column
in which the bed-volume was supported bya1c mhydrophobic
plastic diffusion disk (Fisher Scientiﬁc, Pittsburgh, PA). The column
was then allowed to drain in order to remove the buffer. A solution
of the 8-oxo-dGuo mAb 4E9 (100 µg) in PBS with 0.01% sodium
azide as preservative (1 mL) was diluted with 900 µL of coupling
buffer (0.1 M NaHCO3 and 0.5 M NaCl, pH 8.3). The mAb solution
was added to washed CNBr activated Sepharose 4B gel in a
polystyrene column and shaken overnight at 4 °C. Excess mAb
was removed by washing ﬁve times with 1.0 mL of coupling buffer,
and the gel was allowed to stand in 4.0 mL of 0.1 M Tris-HCl
buffer (pH 8.0) for2ha troom temperature. It was then washed
three times with 5 mL of 0.1 M sodium acetate buffer containing
0.5 M NaCl (pH 4.0) followed by 5 mL of 0.1 M Tris-HCl buffer
containing 0.5 M NaCl (pH 8.0). Finally, 2.0 mL of loading buffer
(0.05 M sodium phosphate buffer containing 0.02% sodium azide,
pH 7.4) was added to the column. The columns were stored at 4
°C until used.
Immunoafﬁnity Puriﬁcation of 8-Oxo-dGuo. Hydrolyzed DNA
from ∼1 × 106 cells (250 µL) was diluted to 1.0 mL with loading
buffer and applied to the immunoafﬁnity column at room temper-
ature. The column was washed with 5.0 mL of loading buffer
followed by washing with 5.0 mL of water. The 8-oxo-dGuo was
eluted with 5.0 mL of water/methanol (1:1). The sample was
evaporated to dryness at room temperature under nitrogen and the
residue dissolved in 200 µL of Chelex-treated HPLC grade water.
Regeneration of Immunoafﬁnity Columns. The columns were
regenerated for future use by washing with 5.0 mL of HPLC grade
water followed by 5.0 mL of loading buffer. They were stored in
2.0 mL of loading buffer at 4 °C. They were used up to 10 times,
and the presence of any carry-over of endogenous 8-oxo-dGuo was
determined by analyzing the internal standard alone. Any carry-
over would have been observed by an increase in the signal for
endogenous 8-oxo-dGuo.
DNA Base Analysis. Calibration curves were prepared using
different concentrations of dGuo (5.0, 10.0, 20.0, 50.0, and 100.0
µg/mL) using system 2 with an injection volume of 10 µL.
Calibration curves were calculated from a linear regression analysis
of LC peak areas of standard samples. A portion of the digested
DNA sample was subjected to the same LC procedure, and normal
dGuo levels were calculated by interpolation from the calibration
curve.
Accuracy and Precision. Standard curves were prepared in the
range of 0.01 ng to 5.00 ng/sample (0.01, 0.05, 0.10, 0.25, 0.50,
1.0, 2.0, and 5.0 ng) and analyzed either directly or after
immunopuriﬁcation of each standard. Quality control (QC) samples
(n ) 5) were prepared for the lower limit of quantitation QC
(LLQC, 0.01 ng), lower QC (LQC, 0.10 ng), middle QC (MQC,
0.50 ng), and high QC (HQC, 1.00 ng) of 8-oxo-dGuo. Control
digested H358 cell DNA from 106 cells was added to each QC
sample and a blank control buffer sample together with [15N5]-8-
oxo-dGuo internal standard (0.76 ng). Samples were then immu-
nopuriﬁed as described above. The 8-oxo-dGuo concentrations in
control DNA and QC samples (to which control DNA had been
added) were determined by LC-MRM/MS. The mean amount of
8-oxo-dGuo present in the control H358 cell DNA (n ) 5) was
then subtracted from the QC samples in order to obtain the accuracy
values. Accuracy was calculated as the percentage deviation from
the theoretical concentration. Within day precision values were
calculated as the coefﬁcient of variation (CV) from the ratio of the
relative standard deviation (SD) to the appropriate mean value
expressed as a percentage for ﬁve replicates.
Comet Assay. A suspension of approximately 7,500 cells (15
µL) was gently mixed with 85 µL of 0.7% low melting point
agarose and was directly added to a slide precoated with 0.9%
normal melting point agarose. The cell mixture was then layered
by spreading it with a coverslip and allowed to gel on the iced
plate for 5 min. After removal of the coverslip, a second layer of
agarose gel was added to cover the surface of the cell-embedded
agarose layer by using the same coverslip. The coverslip was
removed, and the slide was immersed in cell lysis solution [2.5 M
NaCl, 0.1 M Na2-EDTA, 1% Na-sarcosinate, 10 mM Tris-HCl (pH
10.0), 10% DMSO, and 1% Triton X-100] for 1 h. At the end of
lysis, the slide was thoroughly rinsed three times by changing to
the hOGG1 enzyme buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM
Na2-EDTA, and 0.2 mg/mL bovine serum albumin, pH 8.0) at room
temperature. The hOGG1 glycosylase enzyme (0.08 units, 60 µL)
was added to the gel on the slide, and the gel was covered with a
coverslip. The slide was incubated under a humidiﬁed conditions
for 20 min at 37 °C. After incubation, the coverslip was removed,
and the slide was immersed in cold alkali lysis buffer (1 mM Na2-
EDTA and 0.3 M NaOH, pH > 12.0) for 20 min to allow DNA
unwinding. The slide was then subjected to room temperature
electrophoresis at 25 V and 300 mA for 20 min at room temperature
in a horizontal electrophoresis chamber. It was then removed and
immersed in neutralizing buffer (0.4 M Tris-HCl, pH 7.4), and
ﬁnally stained with 80 µL of ethidium bromide (2 µg/mL in PBS)
(27). The amount of DNA damage was determined by visual scoring
according to tail intensity using a minor modiﬁcation of the method
described by Angelis et al. (35). The comet assay was calibrated
using increasing concentrations of H2O2 to yield different levels of
strand breaks in H358 cells. Nucleoids were examined at 200×
magniﬁcation using an epiﬂuorescence microscope (Nikon Eclipse
E600) equipped with an excitation ﬁlter of 535 to 550 nm and a
barrier ﬁlter 590 to 650 nm. To quantify the amount of DNA
damage, 100 comets from each slide (3 slides per measurement)
were then scored as belonging to one of the ﬁve classes according
to the tail intensity of the comet and given a value of 0, 1, 2, 3, or
4 (undamaged, 0; slightly damaged, 1; moderately damaged, 2;
severely damaged, 3; and very severely damaged, 4). The total score
for 100 comets was divided by a factor of 5 to yield an arbitrary
value ranging from 0 (if the counted 100 comets were all
undamaged) to 80 (if the counted 100 comets were all severely
damaged). Cells were then exposed to concentrations of the artiﬁcial
oxidant KBrO3 (as described below) rather than H2O2 as the artiﬁcial
oxidant in order to prevent exposure to peroxyl and hydroxyl
radicals, which could have produced additional DNA lesions.
Results
Purity of [15N5]-8-Oxo-dGuo. The identity and purity of
[15N5]-8-oxo-dGuo was conﬁrmed by LC-MS/MS. The amount
of unlabeled 8-oxo-dGuo was found to be <0.02%.
Quantiﬁcation of 8-Oxo-dGuo. Calibration curves were
obtained by plotting the ratio of the peak areas of 8-oxo-dGuo
to the internal standard ([15N5]-8-oxo-dGuo) against known
amounts of 8-oxo-dGuo in the range of 0.01 ng to 5.00 ng/
sample. A linear regression line (y ) 0.431x + 0.017; r2 )
0.9993) obtained from unextracted standards was identical to
the regression line (y ) 0.480x + 0.021; r2 ) 0.9996) obtained
after immunopuriﬁcation. Amounts of 8-oxo-dGuo in the study
samples were determined by interpolation from the regression
line of the standard curve. The amount of endogenous 8-oxo-
dGuo in the DNA of unstimulated H358 cells was 0.036 ( 0.004
ng/106 cells. The lower limit of quantitation of 8-oxo-dGuo
added to the H358 cells (as deﬁned by better than 20% precision
and accuracy between 80% and 120%) was 0.01 ng/106 cells
(n ) 5) after subtraction of the endogenous 8-oxo-dGuo (0.036
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Accuracies for the quantiﬁcation of LQC (0.10 ng/106 cells, n
) 5), MQC (0.50 ng/106 cells, n ) 5), and HQC (1.00 ng/106
cells, n ) 5) were between 91.9% and 106.8% after the
subtraction of endogenous 8-oxo-dGuo. The precision values
were better than (10% (Table 1).
DNA Extraction Methods. DNA was extracted from H358
cells by two different methods, the NaI method (Wako Kit) and
the cold DNAzol method. DNA dissolved very quickly when
the NaI method was used. In contrast, extensive pipetting was
required with the DNAzol method in order to dissolve the DNA.
However, hydrolysis proceeded with equal efﬁciency for both
methods. Results are presented as means ( SD. The cold
DNAzol method gave slightly lower 8-oxo-dGuo levels of 17.9
( 6.0 8-oxo-dGuo/107 dGuo) than the NaI method (22.8 ( 4.4
8-oxo-dGuo/107 dGuo) (Figure 1). In the presence of deferox-
amine (0.1 mM), artifactual formation of 8-oxo-dGuo was
reduced considerably for both methods (Figure 1). However,
the DNAzol method was signiﬁcantly better (p ) 0.010) (Figure
1). Similar results were observed with the addition of TEMPO
(p ) 0.049, Figure 1). A typical LC-MRM/MS chromatogram
from the analysis of 8-oxo-dGuo in H358 cells containing 2.8
8-oxo-dGuo/107 dGuo obtained by the DNAzol/deferoxamine
method is shown in Figure 2.
8-Oxo-dGuo levels in H358, A549, Hepa-1c1c7, and
HeLa Cells. The basal 8-oxo-dGuo level in DNA from human
bronchoalveolar H358 cells was 2.2 ( 0.4 8-oxo-dGuo/107 dGuo
(mean ( SD) or 5.5 ( 1.0 8-oxo-dGuo/108 nucleotides. Similar
levels were observed in human lung adenocarcinoma A549 cells,
mouse hepatoma Hepa-1c1c7 cells, and human HeLa cervical
epithelial adenocarcinoma cells (Table 2).
Analysis of 8-Oxo-dGuo in H358 Cells by LC-MRM/
MS after DMSO, KBrO3, or MMS Treatment. There was a
linear increase of 8-oxo-dGuo concentration in the H358 cellular
DNA when the cells were treated with increasing concentrations
of DMSO in the range of 0.01% to 2% for 3 h (Figure 3; r2 )
0.996). When DMSO reached a concentration of 2%, there was
23.0 ( 5.4 8-oxo-dGuo/107 dGuo present in the H358 cell DNA.
There was also a linear increase in 8-oxo-dGuo levels when
the cells were treated with increasing concentrations of KBrO3
in the range of 0.05 mM to 2.50 mM (Figure 4; r2 ) 0.962). At
2.50 mM KBrO3, there was 562.2 ( 3.2 8-oxo-dGuo/107 dGuo
present in the DNA (Figure 4). Conversely, the alkylating agent
MMS showed no increase in 8-oxo-dGuo levels in the range of
5 µMt o2 0µM (Figure 5). MMS was dissolved in DMSO to
give a ﬁnal concentration of 2% DMSO in the cell media.
Absolute 8-oxo-dGuo levels in the DNA of cells treated with
20 µM MMS (23.0 ( 3.2/107 dGuo, Figure 5) were not
Table 1. Validation of the 8-Oxo-dGuo Assay in the H358
Cell DNA Hydrolysate
a
QC LLQC LQC MQC HQC
QC amount (ng) 0.010 0.100 0.500 1.000
mean (ng) 0.009 0.092 0.466 1.068
CV (%) 19.4 8.5 3.3 9.5
accuracy (%) 90.0 91.9 93.2 106.9
a The endogenous 8 oxo-dGuo (0.036 ng) was subtracted in order to
obtain the accuracy for each QC sample (n ) 5).
Figure 1. Formation of 8-oxo-dGuo in human bronchoalveolar H358
cell DNA using different isolation and hydrolysis methods. DNAzol
isolation is shown as solid bars and NaI as slanted striped bars. Analyses
were conducted by immunoafﬁnity puriﬁcation and stable isotope
dilution LC-MRM/MS analysis of 8-oxo-dGuo in H358 cell hydrolysate
(106 cells) using Chelex-treated buffers in the absence or presence of
deferoxamine or TEMPO chelators. Data are presented as means (
SD (error bars) from triplicate samples. P values were determined by
an unpaired Student’s t-test.
Figure 2. Immunoafﬁnity puriﬁcation coupled with stable isotope
dilution LC-MRM/MS analysis of 8-oxo-dGuo isolated from H358 cell
DNA using the DNAzol method with deferoxamine to chelate transition
metal ions. The upper panel shows the MRM chromatogram for
endogenous 8-oxo-dGuo (2.8 8-oxo-dGuo/107 dGuo), and the lower
panel shows the internal standard’s chromatogram.
Table 2. Basal 8-Oxo-dGuo Levels in H358, A549,
Hepa-1c1c7, and HeLa Cells
a
8-oxo-dGuo/107 dGuo
H358 cells A549 cells Hepa1c1c7 cells HeLa cells
mean 2.22 4.50 7.00 4.67
SD 0.37 1.72 0.99 1.05
a Analyses were conducted in triplicate.
Figure 3. Linear relationship between DMSO treatment and 8-oxo-
dGuo formation. DMSO-mediated 8-oxo-dGuo formation in H358 cells
was determined by LC-MRM/MS. Data are presented as means ( SD
(error bars) from duplicate samples.
Figure 4. Linear relationship between KBrO3 treatment and 8-oxo-
dGuo formation. KBrO3-mediated 8-oxo-dGuo formation in H358 cells
was determined by LC-MRM/MS. Data are presented as means ( SD
(error bars or within symbols) from duplicate samples.
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vehicle alone (Figure 3).
Analysis of 8-Oxo-dGuo in H358 Cells by the Comet
Assay after KBrO3 or MMS Treatment. H358 cells were
analyzed for comet tail intensities before and after incubation
with hOGG1. Tail intensity values were then converted to SSBs
(arbitrary units) as described above. Addition of the vehicle used
to dissolve KBrO3 (PBS) resulted in SSBs that were close to
the limit of detection in the absence (9.9 ( 2.1) or presence of
hOGG1 (10.5 ( 0.1) (Figure 6). There was a gradual increase
in SSBs in the absence of hOGG1 with increasing concentrations
of KBrO3 to a maximum of 22.2 ( 0.3 (Figure 6). In the
presence of hOGG1, there was a much greater (nonlinear)
increase in SSBs with increasing KBrO3 concentrations to a
plateau of 78.1 ( 1.1 at 2.50 mM KBrO3 (Figure 6). Addition
of the vehicle used to dissolve MMS (2% DMSO) caused a
very slight increase in SSBs in the absence of hOGG1 (12.1 (
2.3) (Figure 5) when compared with that in the PBS vehicle
(9.9 ( 2.1) (Figure 6). A further slight increase in SSBs was
observed with the DMSO vehicle (14.0 ( 2.2) if hOGG1 was
added when compared with that in PBS (10.5 ( 0.1) or with
the absence of hOGG1 (9.9 ( 2.1). A slight increase in SSBs
was detected by the comet assay with increasing concentrations
of MMS. However, no difference was observed in SSB levels
when the assay was performed in the presence or absence of
hOGG1 (Figure 5). SSBs were maximal with 20 µM MMS at
24.7 ( 0.1 in the absence of hOGG1 and at 23.6 ( 0.4 in the
presence of hOGG1.
Analysis of 8-Oxo-dGuo in H358 Cells by LC-MRM/
MS after B[a]P-7,8-dione Treatment. There was a signiﬁcant
increase (p ) 0.002) in the amount of 8-oxo-dGuo after
treatment of H358 cells with B[a]P-7,8-dione (25.8 ( 3.1 /107
dGuo) when compared with that in the vehicle control (10.0 (
2.0/107 dGuo) as shown in Figure 7. Treatment of the cells with
the COMT inhibitor Ro 410961 (3 µM) caused no increase in
8-oxo-dGuo (9.3 ( 0.4 /107 dGuo). However, the addition of
Ro 410961 (3 µM) together with B[a]P-7,8-dione (20 µM)
caused a signiﬁcant increase in 8-oxo-dGuo to 39.6 ( 1.9/107
dGuo when compared with that in B[a]P-7,8-dione alone (p )
0.003, Figure 7).
Discussion
ROS are generated during normal cellular metabolism and
are detoxiﬁed by a suite of antioxidant enzymes including
superoxide dismutases (SODs), catalases, glutathione (GSH)
peroxidases, and thioredoxins (36-38) as well as by dietary
antioxidants (39). There is always a potential for ROS to evade
detoxiﬁcation and cause oxidative damage to cellular DNA (10)
as well as to the trinucleotide precursors of DNA (40). Oxidative
stress-mediated generation of ROS can result from inﬂammation
(41) and viral and bacterial infections (41) as well as from the
metabolism of endogenous molecules such as estrogens (42),
drugs such as etoposide (43), and environmental chemicals such
as B[a]P (44). 8-oxo-dGuo is by far the most studied lesion
that arises through ROS-mediated oxidative damage to DNA
(10).
Three base excision repair (BER) enzymes, human MutY
homologue (hMutY) (45), hOGG1 (46), and hOGG2 (47), are
involved in the repair of 8-oxo-dGuo-derived lesions in DNA,
whereas the hydrolase enzyme MTH1 removes 8-oxo-dGuo
from the trinucleotide pool (48). It is conceivable that these
repair pathways could be overwhelmed by chronic oxidative
stress leading to inactivating mutations in tumor suppressor
genes such as p53 (49) or activating mutations in protoonco-
genes such as Ras (50). It is noteworthy that polymorphisms in
two of the BER enzymes involved in the repair of oxidative
DNA damage are associated with increased cancer risk (51).
Germline mutations predispose individuals to hMutY-associated
polyposis (MAP), an autosomal recessive disorder characterized
by multiple colorectal adenomas and carcinomas (52). hMutY
is a DNA glycosylase, which removes adenines mispaired
opposite 8-oxo-dGuo in double-stranded DNA (53). This
mispairing can arise from either misincorporation of 8-oxo-
dGTP opposite adenine in the template strand or misincorpo-
ration of dATP opposite unrepaired 8-oxo-dGuo in the template
strand during DNA synthesis (54, 55). It has been proposed
that a failure to correct this mispairing of bases gives rise to
the characteristic signature of G f T transversion mutations
Figure 5. MMS-mediated 8-oxo-dGuo formation in H358 cells as
determined by LC-MRM/MS (b), comet assay with hOGG1 (9), or
comet assay without hOGG1 (1). Data are presented as means ( SD
(error bars or within symbols) from duplicate samples.
Figure 6. KBrO3-mediated 8-oxo-dGuo formation in H358 cells as
determined by the comet assay with hOGG1 (9) or the comet assay
without hOGG1 (1). Data are presented as means ( SD (error bars or
within symbols) from duplicate samples.
Figure 7. Analysis of 8-oxo-dGuo in H358 cells by LC-MRM/MS after
treatment with PBS (right slanted stripes), 1% DMSO vehicle (open),
B[a]P-7,8-dione (left slanted stripes), 3 µM COMT inhibitor Ro 410961
(shaded), and 3 µM Ro 410961 + 20 µMB [ a]P-7,8-dione (basket
weave). Data are presented as means ( SD (error bars) from triplicate
samples. P values were determined by an unpaired Student’s t-test.
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carcinoma (52). There are also a number of reports that associate
mutations in hOGG1 (which excises 8-oxo-guanine from DNA)
with increased susceptibility to cancer (56). It has been suggested
that the homozygous Cys326/Cys326 hOGG1 genotype might
be a biomarker of disease susceptibility (57). Clearly, additional
functional and epidemiologic studies are required in order to
further clarify the potential relationship between hOGG1
polymorphisms and cancer (46). However, such studies will be
critically dependent upon the availability of methodology that
can accurately quantify 8-oxo-dGuo (24).
The analysis of 8-oxo-dGuo in cellular DNA using physico-
chemical methods ﬁrst requires the isolation and hydrolysis of
the DNA. This can result in the artifactual oxidation of a small
number of dGuo bases, which results in signiﬁcantly elevated
8-oxo-dGuo values when compared to that in the comet assay
(25). Use of DNAzol instead of the chaotropic agent NaI,
coupled with Chelex-treated buffers and deferoxamine to
complex any residual transition metal ions, was found to
eliminate artifactual oxidation of DNA during isolation and
hydrolysis from human bronchoalveolar H358 cells (Figure 1).
In a typical experiment designed to examine basal 8-oxo-dGuo,
there is a 107 excess of dGuo when compared with 8-oxo-dGuo
after hydrolysis of the DNA. Oxidation of 0.00005% of the
dGuo would have had a signiﬁcant impact on the amount of
8-oxo-dGuo. Therefore, we reasoned that it was essential to
remove the dGuo as rapidly and as efﬁciently as possible using
immunoafﬁnity puriﬁcation. This was coupled with stable
isotope dilution LC-MRM/MS to provide maximal speciﬁcity
(Figure 2). The lower limit of quantitation of 8-oxo-dGuo added
to the H358 cell hydrolysate was 0.01 ng/106 cells, which
corresponded to 1.1 8-oxo-dGuo/107 dGuo. Rigorous validation
of the assay was conducted through analysis of QC samples
prepared by adding known amounts of 8-oxo-dGuo to the H358
cell hydrolysate (Table 1). Availability of this new validated
assay has made it possible to routinely analyze endogenous
concentrations of 8-oxo-dGuo in cellular DNA. Typical levels
of 2.2 ( 0.4 8-oxo-dGuo/107 dGuo or 5.5 ( 1.0 8-oxo-dGuo/
108 nucleotides were observed in unstimulated resting H358 cells
(Figure 1). This is similar to the levels found in other cell types
using the comet assay (25). Furthermore, three other cell types
were shown to have basal 8-oxo-dGuo concentrations in the
same range (Table 2).
A number of previous studies have examined the effects of
different methods for the prevention artifactual formation of
8-oxo-dGuo during isolation and hydrolysis of DNA (17, 18,
30, 31, 58, 59). However, the studies reporting levels of 8-oxo-
dGuo similar to those obtained in the present study employed
LC-electrochemical detection (17, 18, 58). Therefore, the
characterization of 8-oxo-dGuo relied solely upon the retention
time on LC, and therefore, the signal could have arisen from
other electrochemically active endogenous compounds with a
similar retention time. Furthermore, no corrections were made
for recovery of the 8-oxo-dGuo through the isolation procedure
at these low levels. The LC-MS method described in the present
study used a heavy isotopically labeled internal standard, and
therefore, no corrections for recovery through isolation and
analysis of the 8-oxo-dGuo were required. The speciﬁcity of
the LC-MRM/MS method relied upon three parameters: the
analyte had to exhibit the same retention time as the internal
standard, have the correct molecular mass, and give rise to the
correct product ion. No other analytical technique can attain
this level of speciﬁcity. A recent LC-MRM/MS method, which
employed an online solid phase extraction procedure, has
reported 8-oxo-dGuo levels in mouse liver DNA that were an
order of magnitude higher than those found in the present study
(48.0 ( 3.0 8-oxo-dGuo/107 dGuo) (59) and similar to those
obtained in previous LC-MS methods (19-25).
KBrO3 is known to induce oxidative DNA damage; paradoxi-
cally, the oxidation is GSH-dependent (60). It is thought that
the GSH ﬁrst reduces BrO3 to BrO2, which then abstracts one
electron from dGuo to generate a radical cation that adds a
molecule of water at C-8 and leads to the formation of 8-oxo-
dGuo (61). Thus, KBrO3 provides a way to speciﬁcally generate
8-oxo-dGuo in cellular DNA. Unfortunately, a nonlinear
response of 8-oxo-dGuo to increasing concentrations of KBrO3
was observed with the comet/hOGG1 assay in H358 cells
(Figure 6). This nonlinear response, which was observed
previously by Smith et al. (27), makes it difﬁcult to accurately
assess the role of oxidative stress in causing oxidative DNA
damage. The lowest concentration of KBrO3 that was used (50
µM) caused an almost 4-fold increase over the basal level of
8-oxo-dGuo to 16.9 8-oxo-dGuo/107 dGuo. Furthermore, a linear
increase in 8-oxo-dGuo concentrations was observed over the
concentration range of KBrO3 that was used (Figure 4). In
contrast, at higher concentrations of KBrO3, the comet method
did not provide a linear dose-response. Furthermore, there was
no cell lethality during short-term incubations.
Availability of this new stable isotope dilution LC-MS assay
has made it possible for ﬁrst time to assess the effects of several
exogenous compounds on cellular oxidative DNA damage.
Surprisingly, DMSO, which is often used to solubilize exog-
enously added chemicals, caused oxidative DNA damage to the
H358 cells. There was a linear response in 8-oxo-dGuo
formation to increasing amounts of DMSO up to a ﬁnal
concentration of 2% (Figure 3). At low concentrations, DMSO
is also known to induce membrane thinning and to increase the
ﬂuidity of the membrane’s hydrophobic core (62). At higher
concentrations, DMSO induces transient water pores into the
membrane. Therefore, it is conceivable that this could disrupt
mitochondrial membranes causing ROS release and generation
of oxidative DNA damage. DMSO is known to scavenge
hydroxyl radicals (63, 64), which would actually reduce oxi-
dative DNA damage. However, if the 8-oxo-dGuo arose through
the formation of singlet oxygen and endoperoxide intermediates
(65-67) (Scheme 1) as suggested originally by Ravanat et al.
(68, 69), then DMSO would be unable to prevent its formation
(70). The source of the ﬁnal oxidant to make 8-oxo-dGuo is a
matter of some debate. Sakakibara et al. have shown previously
that 8-hydroperoxy-dGuo is not a precursor of 8-oxo-dGuo in
vitro using the peroxyl radical generator 2,2′-azobis-(2-amino-
propane hydrochloride) (AAPH) to modify dGuo (71). In
contrast, when AAPH was used in isolated nuclei, 8-oxo-dGuo
was detected. Subsequently, it was proposed that the oxidant
required to form 8-oxo-dGuo was an adjacent peroxidized
thymidine (dThd) (72). However, it is not clear that the oxidized
dThd would be sufﬁciently close to the dGuo in the DNA to
induce the formation of 8-oxo-dGuo. Therefore, in isolated
nuclei and in cells, it is conceivable that 8-hydroperoxy-dGuo
is processed to 8-oxo-dGuo by an endogenous peroxidase. In
the case of DMSO, the increased amounts of 8-oxo-dGuo
observed with increasing DMSO concentrations (Figure 3),
together with the ability of DMSO to scavenge hydroxyl radicals
(63), argues that singlet oxygen is the source in this case. Cadet’s
group has shown that singlet oxygen could potentially be the
source in other situations (68, 69). In addition, we have
demonstrated previously that singlet oxygen is the likely source
of 8-oxo-dGuo in the presence of CuI and H2O2 (67). In
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chemistry rather than FeII-driven Fenton chemistry is a distinct
possibility for the source of the lesion. However, we cannot
completely rule out the possibility that B[a]P-7,8-dione-mediated
formation of 8-oxo-dGuo occurs through a hydroxyl radical-
mediated pathway.
MMS is a relatively insoluble organic molecule, which
alkylates cellular DNA rather than causing oxidative damage.
It has been used previously as a negative control to determine
whether oxidative stress is being detected erroneously (27). It
is necessary to solubilize MMS using 2% DMSO, which based
on data from our LC-MRM/MS assay would be expected to
induce a small amount of 8-oxo-dGuo formation. In keeping
with this expectation, levels of 8-oxo-dGuo observed by LC-
MRM/MS after treatment of H358 cells with MMS in 2%
DMSO (Figure 4) were similar to the levels observed with 2%
DMSO alone (Figure 3). The comet/hOGG1 assay also detected
a small increase in oxidative DNA damage resulting from the
addition of 2% DMSO to the H358 cells (14.0 ( 2.2) when
compared with that in the PBS vehicle (10.5 ( 0.1). A further
slight increase in SSBs was observed when increasing concen-
trations of MMS were added to the cells (Figure 5). However,
the increase in SSBs was hOGG1-independent, suggesting that
they arose through a methylating pathway that caused strand
breaks rather than through oxidative DNA damage. In contrast,
the LC-MRM/MS assay did not detect an increase in 8-oxo-
dGuo at any of the MMS concentrations that were used (Figure
5).
Availability of this new LC-MRM/MS assay made it possible
to rigorously determine whether B[a]P-7,8-dione, a metabolite,
derived from the metabolic activation of B[a]P-7,8-dihydro-
7,8-diol by AKRs, could induce oxidative DNA damage in
human bronchoalveolar H358 cells. Unfortunately, it was
necessary to solubilize B[a]P-7,8-dione in 1% DMSO. This
vehicle caused a modest increase in oxidative DNA damage in
the H358 cells (Figure 3). The presence of B[a]P-7,8-dione
caused a signiﬁcant increase in 8-oxo-dGuo levels (p ) 0.002,
Figure 7), which suggested that B[a]P-7,8-dione could induce
oxidative stress in the H358 cells. We reasoned that the increase
in oxidative DNA damage resulted from redox cycling of B[a]P-
7,8-dione to the catechol metabolite (Scheme 1). Detoxiﬁcation
of the catechol through COMT-mediated formation of a methyl
ether metabolite would then limit the amount of oxidative
damage that could occur. In keeping with this possibility, the
addition of Ro 410961 (a COMT inhibitor) caused a further
signiﬁcant increase in oxidative DNA damage (p ) 0.003,
Figure 7). This provided compelling evidence that redox cycling
between B[a]P-7,8-dione and its catechol metabolite could occur
in the H358 cells (Scheme 1). The ability of human AKRs to
activate PAH-trans-dihydrodiols to PAH o-quinones has been
extensively studied (73, 74) and has been previously shown to
result in the production of intracellular reactive oxygen species
and change in redox-state in human lung adenocarcinoma A549
cells (44).
In summary, we have eliminated the problems of artifactual
oxidation during the isolation and hydrolysis of cellular DNA.
The new procedure when coupled with immunoafﬁnity puriﬁca-
tion and stable isotope dilution LC-MRM/MS provided a highly
speciﬁc method of 8-oxo-dGuo analysis that permitted basal
concentrations to be determined in resting cells. A linear
dose-response to increasing concentrations of KBrO3 was
observed by LC-MRM/MS. This contrasted with a comet/
hOGG1 assay, which was nonlinear and reached a plateau at
2.50 mM KBrO3. Therefore, the LC-MRM/MS assay has similar
sensitivity to the comet assay in detecting oxidative lesions but
is more speciﬁc. The limit of detection for the LC-MRM/MS
assay was 0.01 ng of 8-oxo-dGuo/106 cells or 1.1 8-oxo-dGuo/
107 dGuo. DMSO when added to the H358 cells was found to
cause oxidative DNA damage, which has implications for
experiments in which exogenous chemicals are dissolved in
DMSO and added to cells in culture. The amount of DMSO
should be kept to a minimum, and rigorous vehicle control
experiments should be conducted. No 8-oxo-dGuo was observed
after the addition of MMS to H358 cells, which provided
additional conﬁdence that the LC-MRM/MS assay was speciﬁc
for oxidative DNA damage. The assay was used to unequivo-
cally demonstrate that B[a]P-7,8-dione (formed by the sequential
action of cytochrome P450, epoxide hydrolase, and AKR1C
enzymes from B[a]P) caused cellular oxidative DNA damage.
This was thought to arise through the generation of ROS from
redox cycling between the B[a]P-7,8-dione and its catechol
metabolite (Scheme 1). Finally, our new LC-MRM/MS assay
will be valuable for assessing the role of oxidative stress in
future functional and epidemiologic studies.
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